Use of the instantaneous wave-free ratio or fractional flow reserve in PCI

New England Journal of Medicine

Volumn 376, Issue 19, 2017, Pages 1824-1834

  Davies, J E ^a   Sen, S ^a   Dehbi, H M ^c   Al Lamee, R ^a   Petraco, R ^a   Nijjer, S S ^a   Bhindi, R ^j   Lehman, S J ^k   Walters, D ^l   Sapontis, J ^m   Janssens, L ⁿ   Vrints, C J ^o   Khashaba, A ^p   Laine, M ^q   Van Belle, E ^r   Krackhardt, F ^s   Bojara, W ^t   Going, O ^u   Harle T ^v   Indolfi, C ^w   Niccoli, G ^x   Ribichini, F ^y   Tanaka, N ^aa   Yokoi, H ^ab   Takashima, H ^ac   Kikuta, Y ^ad   Erglis, A ^af   Vinhas, H ^ag   Canas Silva, P ^ah   Baptista, S B ^ai   Alghamdi, A ^aj   Hellig, F ^ak   Koo, B K ^al   Nam, C W ^am   Shin, E S ^an   Doh, J H ^ao   Brugaletta, S ^ap   Alegria Barrero, E ^aq   Meuwissen, M ^as   Piek, J J ^at   Van Royen, N ^au   Sezer, M ^av   Di Mario, C ^b,z   Gerber, R T ^d   Malik, I S ^a   Sharp, A S P ^e   Talwar, S ^f   Tang, K ^g,h   Samady, H ^aw   Altman, J ^ax   Seto, A H ^ay   Singh, J ^az   Jeremias, A ^ba   Matsuo, H ^ae   Kharbanda, R K ⁱ   Patel, M R ^bb   Serruys, P ^a   Escaned, J ^ar   more..

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b ROYAL BROMPTON HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d East Sussex Healthcare NHS Trust   (United Kingdom)

^e UNIVERSITY OF EXETER   (United Kingdom)

^f Royal Bournemouth General Hospital   (United Kingdom)

^g Basildon Thurrock University Hospitals Foundation NHS Trust   (United Kingdom)

^h ANGLIA RUSKIN UNIVERSITY   (United Kingdom)

ⁱ JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^j ROYAL NORTH SHORE HOSPITAL   (Australia)

^k FLINDERS UNIVERSITY   (Australia)

^l THE PRINCE CHARLES HOSPITAL   (Australia)

^m MONASH UNIVERSITY   (Australia)

ⁿ IMELDA HOSPITAL   (Belgium)

^o ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^p AIN SHAMS UNIVERSITY   (Egypt)

^q HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^r LILLE UNIVERSITY HOSPITAL   (France)

^s CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^t Department of Paediatric Haematology Oncology   (Germany)

^u SANA KLINIKUM OFFENBACH   (Germany)

^v UNIVERSITY OF OLDENBURG   (Germany)

^w UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^x CATHOLIC UNIVERSITY   (Italy)

^y UNIVERSITY HOSPITAL OF VERONA   (Italy)

^z UNIVERSITY OF FLORENCE   (Italy)

^aa TOKYO MEDICAL UNIVERSITY   (Japan)

^ab Fukuoka Sannou Hospital   (Japan)

^ac AICHI MEDICAL UNIVERSITY HOSPITAL   (Japan)

^ad Fukuyama Cardiovascular Hospital   (Japan)

^ae Pauls Stradins Clinical University Hospital ^*  (Japan)

^af PAULS STRADINS CLINICAL UNIVERSITY HOSPITAL   (Latvia)

^ag Department of Rheumatology   (Portugal)

^ah HOSPITAL DE SANTA MARIA   (Portugal)

^ai HOSPITAL PROF DOUTOR FERNANDO FONSECA   (Portugal)

^aj KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

^ak Sunninghill Hospital   (South Africa)

^al Seoul National University Hospital   (South Korea)

^am Dongsan Medical Center   (South Korea)

^an Ulsan University College of Medicine   (South Korea)

^ao Inje University   (South Korea)

^ap HOSPITAL CLÍNIC   (Spain)

^aq HOSPITAL TXAGORRITXU   (Spain)

^ar UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^as AMPHIA HOSPITAL   (Netherlands)

^at ACADEMIC MEDICAL CENTER   (Netherlands)

^au VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^av ISTANBUL UNIVERSITY   (Turkey)

^aw EMORY UNIVERSITY   (United States)

^ax Veterans Affairs Long Beach Healthcare System ^*  (United States)

^ay VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^az WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^ba STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^bb DUKE UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE;

AGED; ARTICLE; BRONCHOSPASM; CARDIOVASCULAR PARAMETERS; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DYSPNEA; FEMALE; FOLLOW UP; FRACTIONAL FLOW RESERVE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; INSTANTANEOUS WAVE FREE RATIO; MAJOR ADVERSE CARDIAC EVENT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT RISK; PATIENT SAFETY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYMPTOM; THORAX PAIN; ACUTE CORONARY SYNDROME; ANGINA PECTORIS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; DIAGNOSTIC IMAGING; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PROCEDURES; RETREATMENT; SEVERITY OF ILLNESS INDEX;

ACUTE CORONARY SYNDROME; AGED; ANGINA PECTORIS; CARDIOVASCULAR DISEASES; CORONARY ANGIOGRAPHY; CORONARY STENOSIS; FEMALE; FOLLOW-UP STUDIES; FRACTIONAL FLOW RESERVE, MYOCARDIAL; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; RETREATMENT; SEVERITY OF ILLNESS INDEX;

EID: 85019495766     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMoa1700445     Document Type: Article

References (32)

1. Di Mario C, Moses JW, Anderson TJ, et al. Randomized comparison of elective stent implantation and coronary balloon angioplasty guided by online quantitative angiography and intracoronary Doppler. Circulation 2000; 102: 2938-44.
2. Kern MJ, Donohue TJ, Aguirre FV, et al. Clinical outcome of deferring angioplasty in patients with normal translesional pressure-flow velocity measurements. J Am Coll Cardiol 1995; 25: 178-87.
3. Serruys PW, Di Mario C, Meneveau N, et al. Intracoronary pressure and flow velocity with sensor-tip guidewires: A new methodologic approach for assessment of coronary hemodynamics before and after coronary interventions. Am J Cardiol 1993; 71: 41D-53D.
4. Pijls NH, van Son JA, Kirkeeide RL, De Bruyne B, Gould KL. Experimental basis of determining maximum coronary, myocardial, and collateral blood flow by pressure measurements for assessing functional stenosis severity before and after percutaneous transluminal coronary angioplasty. Circulation 1993; 87: 1354-67.
5. Gould KL, Kirkeeide RL, Buchi M. Coronary flow reserve as a physiologic measure of stenosis severity. J Am Coll Cardiol 1990; 15: 459-74.
6. Tonino PAL, De Bruyne B, Pijls NHJ, et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 2009; 360: 213-24.
7. Fearon WF, Shilane D, Pijls NHJ, et al. Cost-effectiveness of percutaneous coronary intervention in patients with stable coronary artery disease and abnormal fractional flow reserve. Circulation 2013; 128: 1335-40.
8. Patel MR, Dehmer GJ, Hirshfeld JW, et al. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography. J Thorac Cardiovasc Surg 2012; 143: 780-803.
9. Patel MR, Dehmer GJ, Hirshfeld JW, Smith PK, Spertus JA. ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 2012; 59: 857-81.
10. Windecker S, Kohl P, Alfonso S, et al. 2014 ESC/EACTS guidelines on myocardial revascularization. Eur Heart J 2014; 35: 2541-619.
11. Pijls NHJ, Tonino PAL. The crux of maximum hyperemia: The last remaining barrier for routine use of fractional flow reserve. JACC Cardiovasc Interv 2011; 4: 1093-5.
12. Sen S, Escaned J, Malik IS, et al. Development and validation of a new adenosineindependent index of stenosis severity from coronary wave-intensity analysis: results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) study. J Am Coll Cardiol 2012; 59: 1392-402.
13. Sen S, Asrress KN, Nijjer S, et al. Diagnostic classification of the instantaneous wave-free ratio is equivalent to fractional flow reserve and is not improved with adenosine administration: results of CLARIFY (Classification Accuracy of Pressure-Only Ratios Against Indices Using Flow Study). J Am Coll Cardiol 2013; 61: 1409-20.
14. Petraco R, van de Hoef TP, Nijjer S, et al. Baseline instantaneous wave-free ratio as a pressure-only estimation of underlying coronary flow reserve: results of the JUSTIFY-CFR Study (Joined Coronary Pressure and Flow Analysis to Determine Diagnostic Characteristics of Basal and Hyperemic Indices of Functional Lesion Severity-Coronary Flow Reserve). Circ Cardiovasc Interv 2014; 7: 492-502.
15. Layland J, Oldroyd KG, Curzen N, et al. Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: The British Heart Foundation FAMOUS-NSTEMI randomized trial. Eur Heart J 2015; 36: 100-11.
16. Götberg M, Christiansen EH, Gudmundsdottir IJ, et al. Instantaneous wavefree ratio versus fractional flow reserve to guide PCI. N Engl J Med 2017; 376:1813-23.
17. Petraco R, Park JJ, Sen S, et al. Hybrid iFR-FFR decision-making strategy: implications for enhancing universal adoption of physiology-guided coronary revascularisation. EuroIntervention 2013; 8: 1157-65.
18. Escaned J, Echavarría-Pinto M, Garcia-Garcia HM, et al. Prospective assessment of the diagnostic accuracy of instantaneous wave-free ratio to assess coronary stenosis relevance: results of ADVISE II international, multicenter study (ADenosine Vasodilator Independent Stenosis Evaluation II). JACC Cardiovasc Interv 2015; 8: 824-33.
19. Sen S, Nijjer S, Petraco R, Malik IS, Francis DP, Davies J. Instantaneous wavefree ratio: numerically different, but diagnostically superior to FFR? Is lower always better? J Am Coll Cardiol 2013; 62: 566.
20. van de Hoef TP, Meuwissen M, Escaned J, et al. Head-to-head comparison of basal stenosis resistance index, instantaneous wave-free ratio, and fractional flow reserve: diagnostic accuracy for stenosisspecific myocardial ischaemia. EuroIntervention 2015; 11: 914-25.
21. Dilsizian V, Gewirtz H, Paivanas N, et al. Serious and potentially life threatening complications of cardiac stress testing: physiological mechanisms and management strategies. J Nucl Cardiol 2015; 22: 1198-213.
22. Cerqueira MD, Verani MS, Schwaiger M, Heo J, Iskandrian AS. Safety profile of adenosine stress perfusion imaging: results from the Adenoscan Multicenter Trial Registry. J Am Coll Cardiol 1994; 23: 384-9.
23. Kern MJ, Seto AH. On the search for an "easy" FFR: submaximal hyperemia and NTG-induced translesional pressure drop (Pd/Pa-NTG). Catheter Cardiovasc Interv 2016; 87: 270-2.
24. Mallet ML. Proarrhythmic effects of adenosine: A review of the literature. Emerg Med J 2004; 21: 408-10.
25. van de Hoef TP, van Lavieren MA, Damman P, et al. Physiological basis and long-term clinical outcome of discordance between fractional flow reserve and coronary flow velocity reserve in coronary stenoses of intermediate severity. Circ Cardiovasc Interv 2014; 7: 301-11.
26. Stone GW, Sabik JF, Serruys PW, et al. Everolimus-eluting stents or bypass surgery for left main coronary artery disease. N Engl J Med 2016; 375: 2223-35.
27. Mohr FW, Morice MC, Kappetein AP, et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 2013; 381: 629-38.
28. Mäkikallio T, Holm NR, Lindsay M, et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): A prospective, randomised, open-label, non-inferiority trial. Lancet 2016; 388: 2743-52.
29. Patel MR, Mahaffey KW, Garg J, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med 2011; 365: 883-91.
30. Granger CB, Alexander JH, McMurray JJV, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med 2011; 365: 981-92.
31. Holmes DR Jr, Kar S, Price MJ, et al. Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: The PREVAIL trial. J Am Coll Cardiol 2014; 64: 1-12.
32. von Birgelen C, Basalus MWZ, Tandjung K, et al. A randomized controlled trial in second-generation zotarolimuseluting Resolute stents versus everolimuseluting Xience V stents in real-world patients: The TWENTE trial. J Am Coll Cardiol 2012; 59: 1350-61.